Latest Foresite Capital Management IV, LLC Stock Portfolio
About Foresite Capital Management IV, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Foresite Capital Management IV, LLC reported an equity portfolio of $182.6 Millions as of 30 Sep, 2025.
The top stock holdings of Foresite Capital Management IV, LLC are PHVS, CYTK, . The fund has invested 65.3% of it's portfolio in PHARVARIS N.V. and 13.8% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off KURA ONCOLOGY, INC. (KURA) stocks. They significantly reduced their stock positions in MAZE THERAPEUTICS, INC.. Foresite Capital Management IV, LLC opened new stock positions in CYTOKINETICS INC (CYTK). The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N.V. (PHVS).
The top stock holdings of Foresite Capital Management IV, LLC are PHVS, CYTK, . The fund has invested 65.3% of it's portfolio in PHARVARIS N.V. and 13.8% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off KURA ONCOLOGY, INC. (KURA) stocks. They significantly reduced their stock positions in MAZE THERAPEUTICS, INC.. Foresite Capital Management IV, LLC opened new stock positions in CYTOKINETICS INC (CYTK). The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N.V. (PHVS).
Foresite Capital Management IV, LLC Annual Return Estimates Vs S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| cytokinetics inc | 25,187,900 |
New stocks bought by Foresite Capital Management IV, LLC
Additions
| Ticker | % Inc. |
|---|---|
| pharvaris n.v. | 8.34 |
Additions to existing portfolio by Foresite Capital Management IV, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| maze therapeutics, inc. | -75.25 |
Foresite Capital Management IV, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| kura oncology, inc. | -4,713,410 |
Foresite Capital Management IV, LLC got rid off the above stocks
Sector Distribution
| Sector | % |
|---|---|
| Others | 72.7 |
| Healthcare | 27.3 |
Market Cap. Distribution
| Category | % |
|---|---|
| UNALLOCATED | 72.7 |
| MID-CAP | 17.3 |
| SMALL-CAP | 10 |
Stocks belong to which Index?
| Index | % |
|---|---|
| Others | 76.2 |
| RUSSELL 2000 | 23.8 |
Foresite Capital Management IV, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Foresite Capital Management IV, LLC
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| CYTK | cytokinetics inc | 13.79 | 458,295 | 25,187,900 | new | |||
| KURA | kura oncology, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| LYEL | lyell immunopharma, inc. | 7.12 | 800,399 | 12,998,500 | unchanged | 0.00 | ||
| PHVS | pharvaris n.v. | 65.29 | 4,778,580 | 119,226,000 | added | 8.34 | ||
| RLAY | relay therapeutics, inc. | 2.86 | 1,000,000 | 5,220,000 | unchanged | 0.00 | ||
| XENE | xenon pharmaceuticals inc. | 3.52 | 160,000 | 6,424,000 | unchanged | 0.00 | ||
| maze therapeutics, inc. | 7.42 | 522,657 | 13,552,500 | reduced | -75.25 | |||